Pharma stocks a growing healthcare sub-segment
Singapore
EVEN though pharmaceuticals is one of the smaller sub-segments in the Singapore Exchange's (SGX's) cluster of healthcare stocks, its year-to-date market cap-weighted average total return of 7.3 per cent is almost double that of the 3.8 per cent generated by the SGX All Healthcare Index - the benchmark for listed healthcare companies here.
The six stocks are: Tianjin ZhongXin Pharmaceutical Group, Haw Par Corporation, iX Biopharma, Suntar Eco-City, Pharmesis International and Star Pharmaceutical.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Oil settles higher on supply concerns in the Mid-East, economic woes subdue gains
S-Reits falter as investors weigh possibility of zero rate cuts in 2024
CapitaLand Investment posts total revenue of S$650 million for Q1
Europe: Stoxx 600 logs best day in three months as banks shine
US: Stocks rally after strong tech results
Porsche posts Q1 profit drop on ramp-up costs